Insider · CIK 0001886608
Kimberly Bullock Gatling
Files at CULP (CULP INC). First filing Dec 28, 2023, latest Mar 27, 2026.
In brief
Kimberly Bullock Gatling files SEC Form 4 as director at CULP (CULP INC). Since Dec 28, 2023, Kimberly Bullock Gatling has reported 4 open-market buys worth $38k and 0 open-market sells worth $0, the latest filed on Mar 27, 2026.
After Kimberly Bullock Gatling's past buys, the stock trailed the S&P 500 by a median 30.3% over six months (n = 3), and 33% of those buys were ahead of the index at six months. InsiderTell labels that a negative record.
The newest scored trade: bought $5,382 of CULP on Mar 26, 2026, filed Mar 27, 2026, scored 48 (moderate). In the last 12 months: 1 buy worth $5,382 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CULP: CULP INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | CULP INC | $5,382 1,812 shares | +4% | 0% from low-48% from high | |
| 41Moderate | CULP INC | $10k 2,347 shares | +7% | +21% from low-35% from high | |
| 33Weak | CULP INC | $12k 2,090 shares | +6% | +19% from low-11% from high | |
| 21Weak | CULP INC | $10k 1,785 shares | +8% | +34% from low-4% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 24, 2026 | CULP CULP INC | MOption exercise Common Stock | +13,190 | $0.00 | $0 | 62,592 | 19 d ago |
| Sep 23, 2026 | CULP CULP INC | MOption exercise Restricted Stock Unitsderivative | -13,190 | $0.00 | $0 | 0 | 19 d ago |
| Sep 24, 2026 | CULP CULP INC | AGrant or award Restricted Stock Unitsderivative | +12,941 | $0.00 | $0 | 12,941 | 19 d ago |
| Mar 26, 2026 | CULP CULP INC | POpen-market purchase Common Stock | +1,812 | $2.97 | $5,382 | 49,402 | Mar 27, 2026 |
| Sep 24, 2025 | CULP CULP INC | MOption exercise Common Stock | +9,197 | $0.00 | $0 | 47,590 | Sep 25, 2025 |
| Sep 24, 2025 | CULP CULP INC | MOption exercise Restricted Stock Unitsderivative | -9,197 | $0.00 | $0 | 0 | Sep 25, 2025 |
| Sep 25, 2025 | CULP CULP INC | AGrant or award Restricted Stock Unitsderivative | +13,064 | $0.00 | $0 | 13,064 | Sep 25, 2025 |
| Sep 22, 2025 | CULP CULP INC | POpen-market purchase Common Stock | +2,347 | $4.30 | $10k | 38,393 | Sep 23, 2025 |
| Dec 30, 2024 | CULP CULP INC | POpen-market purchase Common Stock | +2,090 | $5.83 | $12k | 36,046 | Jan 2, 2025 |
| Dec 26, 2023 | CULP CULP INC | POpen-market purchase Common Stock | +1,785 | $5.63 | $10k | 23,117 | Dec 28, 2023 |
Questions about Kimberly Bullock Gatling
Answered from the filings on this page, as of the latest one.
Is Kimberly Bullock Gatling buying or selling?
In the last 12 months Kimberly Bullock Gatling reported 1 open-market buy worth $5,382 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $5,382 of CULP on Mar 26, 2026. Grants, option exercises and tax withholding are not counted.
How did Kimberly Bullock Gatling's past buys perform?
Measured from the first close after each filing, the stock trailed the S&P 500 by a median 30.3% over six months across 3 past buys, with 33% ahead of the index. Past results describe what happened; they do not predict the next trade.
Where does Kimberly Bullock Gatling file Form 4?
Kimberly Bullock Gatling has filed Form 4 at CULP (CULP INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.